Deficiency of PXR decreases atherosclerosis in apoE-deficient mice

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

(2011) Zeneng Wang et al.   NATURE

A Role of the Bile Salt Receptor FXR in Atherosclerosis

(2010) Jurre Hageman et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Nuclear Receptors and Inflammation Control: Molecular Mechanisms and Pathophysiological Relevance

(2010) Wendy Huang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Modulation of T Lymphocyte Function by the Pregnane X Receptor

(2010) S. Dubrac et al.   JOURNAL OF IMMUNOLOGY

The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population

(2009) Yingchang Lu et al.   ATHEROSCLEROSIS

Activation of PXR induces hypercholesterolemia in wild-type and accelerates atherosclerosis in apoE deficient mice

(2009) Changcheng Zhou et al.   JOURNAL OF LIPID RESEARCH

Activation of the Nuclear Receptor PXR Decreases Plasma LDL-Cholesterol Levels and Induces Hepatic Steatosis in LDL Receptor Knockout Mice

(2009) Menno Hoekstra et al.   MOLECULAR PHARMACEUTICS

Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice

(2008) Jennifer J. Manning-Tobin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

PXR agonism decreases plasma HDL levels in ApoE⁎3-Leiden.CETP mice

(2008) Willeke de Haan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Regulatory Cross-Talk between Drug Metabolism and Lipid Homeostasis: Constitutive Androstane Receptor and Pregnane X Receptor Increase Insig-1 Expression

(2008) A. Roth et al.   MOLECULAR PHARMACOLOGY

Imaging of atherosclerotic cardiovascular disease

(2008) Javier Sanz et al.   NATURE

Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis

(2007) Jie Zhou et al.   GASTROENTEROLOGY